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The present review describes new advances in our understanding of the role of glial cells in the
pathogenesis of glaucoma. It is becoming clear that retinal glia should not be studied in isolation in
glaucoma because glia have dynamic and diverse interactions with a range of different cell types that
could influence the disease process.
Recent findings
Microglial activity is modulated by signals from retinal ganglion cells and macroglia that influence RGC
survival in various models of injury. New studies suggest that circulating monocytic populations may play a
role in mediating the immune response to glaucoma. Astrocytes have been found to develop discrete
localized processes that interact with a specific subset of retinal ganglion cells, possibly responding to the
expression of phagocytic signals by stressed retinal ganglion cells.
Summary
Retinal glia constitute a highly versatile population that interacts with various cells to maintain homeostasis
and limit disease. Defining the mechanisms that underlie glial communication could enable the
development of more selective therapeutic targets, with great potential clinical applications.
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Glaucoma is an optic neuropathy that predomi-
nantly affects retinal ganglion cells (RGCs),
although evidence is accumulating that glial cells
in the retina also play a major role in the pathogen-
esis of this important cause of irreversible blindness.
Retinal glia consist of several populations of multi-
functional, highly adaptable cells that mediate nor-
mal retinal function through close relations with a
variety of different cell types. The importance of
these interactions and new insight into the possible
ways in which they influence our understanding of
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MACROPHAGES IN THE RETINA
Microglia are resident immune cells normally found
in the central nervous system (CNS) and retina that
play an essential role in the innate immune
response. Microglia were first described by del Rio-
Hortega in 1932 as the nonneuronal, nonastrocytic
‘third element of the CNS’ and show considerable
homology with markers for monocytes and mono-
cyte-derived macrophages including F4/80, CD11b
and Iba-1 [1,2]. Together with astrocytes and Müller
glia, they help to maintain homeostasis in the retinaht © 2015 Wolters Kluwe
rs Kluwer Health, Inc. All rights resethrough regulating ion exchange, glucose and neu-
rotransmitter transport. Microglia also have an
important function as highly specialized ‘policing
cells’ that continuously survey the microenviron-
ment and quickly respond to neuronal injury by
phagocytosing potentially harmful neuronal debris
to limit damage, secreting local inflammatory
mediators and communicating with other potential
immune effector cells [3]. The transformation of
surveying microglia into alerted or reactive states,
in response to a perceived threat, is triggered by
signals from other components of the immune sys-
tem, as well as the expression of neuronal ligands
such as fractalkine (CX3CL1) or CD200 [4
&
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KEY POINTS
 Changes in glial status and function precede retinal
ganglion cell (RGC) changes in glaucoma.
 Glial activity is modulated by communication with
neurons, as well as both resident and circulating
populations of immune cells.
 Further studies are required to determine the extent to
which these interactions influence RGC health in
glaucoma, to harness this knowledge for clinical use.
GlaucomaMicroglia are thought to arise from yolk sac
macrophages that enter the primitive brain during
early fetal development, although it is now believed
that circulating monocytes may also subsequently
invade the CNS and differentiate into microglia in
the early postnatal stages [5
&&
]. In adults, there
appears to be a clear distinction between bone
marrow-derived cells and the resident microglial
population under normal conditions in which the
blood–brain barrier has not been breached [6].
Under certain inflammatory conditions, however,
including neurodegenerative diseases with an
underlying inflammatory disorder such as multiple
sclerosis or Alzheimer’s disease, bone marrow-
derived circulating progenitor cells may supplement
resident microglial populations [7,8].
Our perspective on the importance of microglia
in glaucoma is gradually becoming clearer. Studies
using the DBA/2J mouse model of glaucoma, which
are an inbred strain of mice that spontaneously
develop progressive glaucoma, suggest that changes
to the location and activation status of microglia
occur at the early stages of the disease, preceding
detectable RGC disease [9]. Other studies in which
translimbal trabecular laser photocoagulation was
used to induce intraocular pressure (IOP) elevation
in rats have also shown that elevated IOP increases
both microglial activity and density in the retina,
optic nerve and tract before any sign of RGC axonal
loss [10]. Microglial in the laminar zone between the
optic nerve head (ONH) and myelinated optic nerve
show the earliest changes in DBA/2J mice, corre-
sponding to the location where axonal damage is
first thought to occur [11].
It is possible that an increase in microglial pro-
liferation and activation could have a detrimental
effect on RGCs via secretion of proinflammatory
cytokines such as interleukin-6, tumour necrosis
factor-alpha (TNF-a) and reactive oxygen species
[3]. Consistent with this theory, inactivation of
microglia using minocycline seems to have a neuro-
protective effect on RGCs in DBA/2J mice [12]. Copyright © 2015 Wolters Kluwer 
74 www.co-ophthalmology.comDeficiencies in the chemokine fractalkine, which
is produced by neurones and moderates microglial
activity under normal conditions, have also been
found to be associated with increased RGC loss in an
experimental mouse model of glaucoma [13
&&
]. The
present study provides the first evidence of RGC-
mediated dampening of microglial reactivity under
normal circumstances, and that disruption of this
signalling pathway exacerbates RGC death because
of glaucoma.
At present, the role of infiltrating monocyte-
derived macrophages in glaucoma is less certain.
Circulating monocytes were seen to invade the
retina and optic nerve in aged glaucomatous DBA/
2J mice, whereas ocular irradiation that reduced
the presence of these cells resulted in an enhanced
RGC survival [14]. Increasing the number of mono-
cytes in the peripheral vasculature, however, was
also reported to have a protective effect in mice
that experienced high IOP secondary to anterior
chamber cannulation [15]. These differences in
the RGC response to monocyte-derived macro-
phages in the glaucomatous eye are still not well
understood, but may well relate to specific aspects
of the individual disease models that have yet to
be defined.
Retinal glia play an important part in maintain-
ing synaptic activity in the retina by transporting
neurotransmitters and preserving biochemical
homeostasis through modulation of ion channel
distribution. Microglia in particular seem to have
a unique involvement with retinal synapses, as
demonstrated by studies that show recurring inti-
mate contact between their filopodia and dendritic
spines [16]. Complement factor C1q is also pro-
foundly upregulated on RGC synapses with increas-
ing severity of glaucoma in DBA/2J mice. This is
thought to present a target for subsequent elimin-
ation by microglial engulfment [17]. Whether this
process of synaptic stripping serves the purpose of
limiting inflammatory debris, or, conversely,
represents a dysfunctional state that contributes
to RGC death, remains to be seen.MÜLLER CELLS
Other important glial cell populations in the eye
include astrocytes and Müller cells. Müller cells are
the principal macroglial cells found in the retina
and are radially oriented cells spanning the entire
thickness of the retina. The Müller cell body lies in
the inner nuclear layer and elongates into two main
trunks that pass towards the inner limiting
membrane overlying the RGC/retinal nerve fibre
layer as well as to the outer limiting membrane
directly adjacent to photoreceptors. Müller cellsHealth, Inc. All rights reserved.
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Müller endfoot adjacent to the inner limiting mem-
brane and by apical microvilli close to the photo-
receptor layer. Numerous processes protrude from
the main trunks of Müller cells, which interact with
various neuronal cell types in the different layers of
the retina.
Müller cells are thought to play an essential role
in maintaining the structural integrity of the retina
and are also important regulators of retinal cell
metabolism. They act as an anatomical conduit
between retinal neurones and the cellular environ-
ment, maintaining retinal homeostasis by partici-
pating in essential processes such as glucose
metabolism, antioxidant production, ion/substrate
exchange and vascular regulation. A newer idea
about the unique properties of Müller cells is that
they may also act as light-guiding fibres because of
their structure and specific refractive index, relative
to the inner and outer retinal surfaces that they
bridge [18].
Müller cells moderate neurotransmitter levels
by providing precursor substrates to neurones and
preventing toxic accumulation of glycine, gamma-
aminobutyric acid and glutamate in the retina [19]
that could otherwise lead to the activation of proa-
poptotic signalling in neurones [20]. Müller cells
also promote RGC survival through the production
of neurotrophic factors such as ciliary neurotrophic
factor, which has been shown to have potent neuro-
protective effects in glaucoma [21].
In glaucoma, the activation of Müller cells also
plays a crucial role in driving microglial migration
and the recruitment of other immune cells within
the retina [22]. The combined actions of astrocytes
and Müller cells provide a supportive environment
for the modulation of synaptic activity through the
activation of microglia and the maintenance of
ionic and neurotransmitter levels [23]. New evi-
dence suggests that upregulation of microglial–
macroglial cross-talk occurs in response to optic
nerve axotomy or excitotoxic injury to the retina,
which could serve to modulate microglial activity to
promote a return to baseline quiescence [24
&&
].
Müller cells may also form an adhesive cellular
scaffold that guides the movement of microglia
across various retinal layers to mount an effective
response to injury [25].
Recent studies of the biomechanical properties
of Müller cells have shown that, perhaps surpris-
ingly, they are softer than neurones, challenging the
concept of a ‘hard’ scaffold for retinal cells [26]. This
interesting feature of Müller cells suggests that they
may provide cushioning support that helps to
resist physical forces acting on the retina, such as
traumatic injury or raised IOP. It is also possible that Copyright © 2015 Wolters Kluwe
1040-8738 Copyright  2015 Wolters Kluwer Health, Inc. All rights resea soft, pliant environment provides a more con-
ducive environment for neurite outgrowth. In
glaucoma, Müller cells undergo similar reactive
changes that mirror the response described in
astrocytes at the ONH with hypertrophy and for-
mation of a glial scar in rodent models of the
disease [27]. Furthermore, the upregulation of
intermediate filaments such as nestin, vimentin
and glial fibrillary acidic protein (GFAP) may
increase the stiffness of these cells, reversing the
benefits of the ‘soft’ perineuronal environment
described above [28,29].ASTROCYTES
Astrocytes are the major glial cell type found at the
ONH. These cells line the lamina cribrosa pores and
blood vessels to form a dense network that
resembles a honeycomb spanning the ONH. RGC
axons passing through the lamina cribrosa are
organized into bundles interspersed between astro-
cytic processes, which provide support by secreting
extracellular matrix molecules and also form part of
the blood–retinal barrier.
In several models of glaucoma, astrocytes appear
to demonstrate increased GFAP immunoreactivity
as well as extracellular matrix remodelling at the
ONH. GFAP is an intermediate filament of the
glial cell cytoskeleton, and becomes increasingly
expressed during the transformation of mature,
quiescent astrocytes into their ‘reactive’ state. It
has been known for some time that astrocytes in
the glaucomatous lamina cribrosa undergo morpho-
logical changes that mimic the CNS injury response,
characterized by hypertrophy of the cell body,
and a generalized loss of thick processes [30]. More
recent studies of cross-bred mouse strains that
develop spontaneous glaucoma in addition to hav-
ing GFP-expressing astrocytes have also demon-
strated the presence of long, thin, non-GFAP-
expressing processes in astrocytes responding to
high IOP. These fine processes that project into
the axon bundle appear to be confined to specific
regions of each astrocyte [31
&
] and may only be in
contact with several RGC axons at each point,
instead of spanning across the diameter of the
optic nerve.
The precise function of these fine processes is
still unknown, but it is possible that they have a
limited structural role because they do not make up
part of the glial tubes that surround RGC axon
bundles. Instead, they may mediate local inflamma-
tory responses through TNF-a/TNF-receptor signal-
ling and nuclear factor-kB activation, and regulate
autophagy via the serine/threonine protein kinase
mammalian target of rapamycin pathway [32]. Thisr Health, Inc. All rights reserved.
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Glaucomasegregated pattern of astrocyte–RGC interaction
could explain the sectorial degeneration of RGC
axons, which is typically seen in glaucoma.
Another interesting possibility is that these
processes may have phagocytic properties that act
on damaged RGCs. Astrocytes within the post-
laminar ONH myelination transition zone of
healthy eyes have recently been found to express
the phagocytosis-related gene Mac-2 [33]. Expres-
sion of this gene becomes upregulated in glaucoma
in astrocytes of the laminar and orbital regions of
the optic nerve, suggesting that certain astrocytes
could have intrinsic phagocytic abilities that aid in
the clearance of harmful RGC axonal debris.
Neurones are known to constitutively express ‘eat-
me’ or ‘do-not-eat-me’ signals in the CNS [34
&&
],
which may be mirrored in RGCs to regulate this
phagocytic response.
In addition to their location at the ONH, astro-
cytes are also found spread out across the retinal
nerve fibre layer (RNFL) where they form a network
of spindle-shaped cells with close associations with
retinal vasculature. A rodent experimental model of
glaucoma has suggested a generalized loss of astro-
cyte coverage over the RNFL, and subtle morpho-
logical changes were seen in both the injured and
the uninjured eyes of the same animal, although
the reason for this ‘sympathetic’ response seen in
the fellow retina is still unknown [35].
Astrocytic dysregulation of vascular permeability
and endothelial cell activation is also increasingly
thought to be a prominent feature of glaucoma. In
addition to the reports of enhanced transendothelial
monocyte migration seen in experimental models of
glaucoma described earlier, patients with primary
open-angle glaucoma have been observed to have
increased vascular permeabilityat theopticdiscusing
fluorescein angiography [36]. A postmortem veteri-
nary study of dogs who experienced goniodysgenesis
and primary glaucoma showed evidence that
suggests a compromised blood–retinal barrier in dis-
eased eyes as well [37].
Paradoxically, or perhaps in response to the
breakdown of the blood–retinal barrier, reactive
ONH astrocytes have also been found to express
increased levels of endothelin-1 (ET-1) receptors in
experimental glaucoma [38]. ETs belong to a family
of potent vasoconstrictive molecules that are
produced by astrocytes in response to stretch [39]
and act in a paracrine loop on ET receptors to
cause proliferation and activation of astrocytes,
in addition to impeding ocular blood circulation
[40]. Experimental glaucoma models of both rat and
DBA/2J mice have been demonstrated to have
increased expression of ET-1 correlating with
neuronal loss [41,42]. Elevated levels of ET-1 have Copyright © 2015 Wolters Kluwer 
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of glaucoma patients, suggesting that these mole-
cules may indeed have a potential involvement in
the human disease [43].CONCLUSION
Recent studies have provided increasing evidence
that retinal glia do not perform isolated functions
but are engaged in various important relations with
other cells in the retina relevant to optic nerve
diseases such as glaucoma. These interactions are
not limited to neuron–glia communication, but
also extend to endothelial cells that line blood
vessels, circulating cells from the peripheral blood
supply and possibly even the contralateral eye.
Certainly, modulation of homeostatic pro-
cesses that favour neuroprotection over damaging
chronic inflammation appears to be a key factor
in mediating the consequences of glial activity.
Cross-talk between microglia and RGCs as well as
other types of retinal glia may be pivotal in manag-
ing the delicate balance of ‘friend or foe’ cues that
determine glial behaviour in the presence of dis-
ease. Therapeutic strategies that selectively target
certain aspects of glial signalling in the retina
could have a great potential for future clinical
applications.
In conclusion, a deeper understanding of the
complex network of glial interactions in the retina
would undoubtedly produce much insight into the
pathogenesis of glaucoma.Acknowledgements
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